Lista de obras - Hans J van der Vliet - Dominio Público Uruguay

A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells.

artículo científico publicado en 2017

A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer.

artículo científico publicado en 2016

A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors

artículo científico publicado en 2002

A safety and immunogenicity study of immunization with hVEGF26-104/RFASE in cynomolgus monkeys

artículo científico publicado en 2018

A space-occupying lesion of the skull base, masked by nasopharyngeal lymphatic tissue hypertrophy and causing cranial nerve dysfunction in an HIV-infected patient.

artículo científico publicado en 2002

Activated iNKT cells promote Vγ9Vδ2-T cell anti-tumor effector functions through the production of TNF-α.

artículo científico publicado en 2011

Aminobisphosphonates inhibit dendritic cell-mediated antigen-specific activation of CD1d-restricted iNKT cells.

artículo científico publicado en 2015

An α-galactosylceramide nose job shapes up iNKT cells

artículo científico publicado en 2012

Attenuation of invariant natural killer T-cell anergy induction through intradermal delivery of alpha-galactosylceramide

artículo científico publicado en 2010

Bispecific antibody platforms for cancer immunotherapy

artículo científico

Body mass index and 20-specific cancers: re-analyses of dose-response meta-analyses of observational studies

artículo científico publicado en 2017

Breast-cancer adjuvant therapy with zoledronic acid

scientific article published on 01 January 2012

Bulldozing β-linked glycolipids for recognition by invariant NKT cells

artículo científico publicado en 2012

CD1d-restricted antigen presentation by Vγ9Vδ2-T cells requires trogocytosis

artículo científico publicado en 2014

Case 19-2009: Carcinoma of the gastroesophageal junction

artículo científico publicado en 2009

Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage

artículo científico publicado en 2001

Circulating Valpha24+Vbeta11+ NKT cell numbers and dendritic cell CD1d expression in hepatitis C virus infected patients.

artículo científico publicado en 2005

Circulating invariant natural killer T-cell numbers predict outcome in head and neck squamous cell carcinoma: updated analysis with 10-year follow-up

artículo científico publicado en 2012

Clinical evaluation of the efficacy of methylnaltrexone in resolving constipation induced by different opioid subtypes combined with laboratory analysis of immunomodulatory and antiangiogenic effects of methylnaltrexone

artículo científico publicado en 2014

Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection.

artículo científico publicado en 2010

Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer

artículo científico publicado en 2016

Correction: Prevention of Vγ9Vδ2 T Cell Activation by a Vγ9Vδ2 TCR Nanobody

artículo científico publicado en 2017

Cutting edge: Rapid recovery of NKT cells upon institution of highly active antiretroviral therapy for HIV-1 infection

artículo científico publicado en 2006

Differential effects of inhibitors of the PI3K/mTOR pathway on the expansion and functionality of regulatory T cells.

artículo científico publicado en 2016

Effects of alpha-galactosylceramide (KRN7000), interleukin-12 and interleukin-7 on phenotype and cytokine profile of human Valpha24+ Vbeta11+ T cells

artículo científico publicado en 1999

Ex vivo analysis of resident hepatic pro-inflammatory CD1d-reactive T cells and hepatocyte surface CD1d expression in hepatitis C.

artículo científico publicado en 2013

Exploiting regulatory T-cell populations for the immunotherapy of cancer.

artículo científico publicado en 2007

Exploiting the CD1d-iNKT cell axis for potentiation of DC-based cancer vaccines

artículo científico publicado en 2014

Expression of granzyme B during primary cytomegalovirus infection after renal transplantation

artículo científico publicado en 1999

Generation and characterization of CD1d-specific single-domain antibodies with distinct functional features

artículo científico publicado en 2016

Generation of antitumor invariant natural killer T cell lines in multiple myeloma and promotion of their functions via lenalidomide: a strategy for immunotherapy.

artículo científico publicado en 2008

Gram-positive bacteria: a major microbial ‘turn-on’ for invariant NKT cells

scientific article published on 01 January 2012

Hepatitis C Virus (HCV)-Specific CD8+ Cells Produce Transforming Growth Factor That Can Suppress HCV-Specific T-Cell Responses

artículo científico publicado en 2007

High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status

scientific article published on 25 October 2016

Highly specific and potently activating Vγ9Vδ2-T cell specific nanobodies for diagnostic and therapeutic applications.

artículo científico publicado en 2016

Human natural killer T cells acquire a memory-activated phenotype before birth

artículo científico publicado en 2000

IPEX as a result of mutations in FOXP3

artículo científico publicado en 2007

Immunological effects of everolimus in patients with metastatic renal cell cancer

artículo científico publicado en 2017

In Vivo Efficacy of Umbilical Cord Blood Stem Cell-Derived NK Cells in the Treatment of Metastatic Colorectal Cancer

artículo científico publicado en 2017

Invariant natural killer T cells and immunotherapy of cancer.

artículo científico publicado en 2008

Irinotecan-induced dysarthria.

artículo científico publicado en 2012

Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma

scientific article published on 01 March 2007

MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursors.

artículo científico publicado en 2002

Mechanisms of intimate and long-distance cross-talk between glioma and myeloid cells: how to break a vicious cycle.

artículo científico publicado en 2014

Megacolon during treatment with lactulose

artículo científico publicado en 2004

Multiple pseudotumors in IgG4-associated multifocal systemic fibrosis

artículo científico publicado en 2004

Myocardial air collections as a result of infection with a gas producing strain of Escherichia coli.

artículo científico publicado en 2004

Natural Killer T cells

artículo científico publicado en 2002

Natural killer T cell-based cancer immunotherapy

artículo científico publicado en 2006

Nuancing the proposed role of NKT cells in aging ⬇️

artículo científico publicado el 1 de marzo de 2011

Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis

artículo científico publicado en 2018

Peripheral blood IFN-gamma-secreting Valpha24+Vbeta11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load

scientific article published on 01 August 2005

Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-Based Chemoradiation in Locally Advanced Pancreatic Cancer.

artículo científico publicado en 2015

Polarization of Valpha24+ Vbeta11+ natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cells

scientific article published on 01 July 2003

Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15

scientific article published on 01 January 2001

Preoperative chemoradiation therapy in combination with panitumumab for patients with resectable esophageal cancer: the PACT study

artículo científico publicado en 2014

Prevention of Vγ9Vδ2 T Cell Activation by a Vγ9Vδ2 TCR Nanobody.

artículo científico publicado en 2016

Quantification of Bax/Bcl-2 ratios in peripheral blood lymphocytes, monocytes and granulocytes and their relation to susceptibility to anti-Fas (anti-CD95)-induced apoptosis

scientific article published on 01 November 1997

Randomized phase 2 study of gemcitabine and cisplatin with or without vitamin supplementation in patients with advanced esophagogastric cancer.

artículo científico publicado en 2018

Response to Comment on "mTOR Inhibition Per Se Induces Nuclear Localization of FOXP3 and Conversion of Invariant NKT (iNKT) Cells into Immunosuppressive Regulatory iNKT Cells".

artículo científico publicado en 2015

Schistosomiasis

artículo científico publicado en 2005

Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection

artículo científico publicado en 2002

Severe toxicity of capecitabine following uncomplicated treatment with 5-fluorouracil/leucovorin

artículo científico publicado en 2010

Standardized and flexible eight colour flow cytometry panels harmonized between different laboratories to study human NK cell phenotype and function.

artículo científico publicado en 2017

Statistical controversies in clinical research: overlap and errors in the meta-analyses of microRNA genetic association studies in cancers.

artículo científico publicado en 2017

Synergistic effect of KRN7000 with interleukin-15, -7, and -2 on the expansion of human V alpha 24+V beta 11+ T cells in vitro

artículo científico publicado en 2000

The CD8+ granzyme B+ T-cell subset in peripheral blood from healthy individuals contains activated and apoptosis-prone cells.

artículo científico publicado en 1998

The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments.

artículo científico

The effects of systemic treatment with aminobisphosphonates and statins on circulating Vγ9Vδ2-T cells in patients with advanced cancer

artículo científico publicado en 2017

The immunoregulatory role of CD1d-restricted natural killer T cells in disease.

artículo científico publicado en 2004

Vγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy.

artículo científico publicado en 2014

mTOR Inhibition Per Se Induces Nuclear Localization of FOXP3 and Conversion of Invariant NKT (iNKT) Cells into Immunosuppressive Regulatory iNKT Cells

artículo científico publicado en 2015

Lista de obras de Hans J van der Vliet

A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells.

A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer.

A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors

A safety and immunogenicity study of immunization with hVEGF26-104/RFASE in cynomolgus monkeys

A space-occupying lesion of the skull base, masked by nasopharyngeal lymphatic tissue hypertrophy and causing cranial nerve dysfunction in an HIV-infected patient.

Activated iNKT cells promote Vγ9Vδ2-T cell anti-tumor effector functions through the production of TNF-α.

Aminobisphosphonates inhibit dendritic cell-mediated antigen-specific activation of CD1d-restricted iNKT cells.

An α-galactosylceramide nose job shapes up iNKT cells

Attenuation of invariant natural killer T-cell anergy induction through intradermal delivery of alpha-galactosylceramide

Bispecific antibody platforms for cancer immunotherapy

Body mass index and 20-specific cancers: re-analyses of dose-response meta-analyses of observational studies

Breast-cancer adjuvant therapy with zoledronic acid

Bulldozing β-linked glycolipids for recognition by invariant NKT cells

CD1d-restricted antigen presentation by Vγ9Vδ2-T cells requires trogocytosis

Case 19-2009: Carcinoma of the gastroesophageal junction

Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage

Circulating Valpha24+Vbeta11+ NKT cell numbers and dendritic cell CD1d expression in hepatitis C virus infected patients.

Circulating invariant natural killer T-cell numbers predict outcome in head and neck squamous cell carcinoma: updated analysis with 10-year follow-up

Clinical evaluation of the efficacy of methylnaltrexone in resolving constipation induced by different opioid subtypes combined with laboratory analysis of immunomodulatory and antiangiogenic effects of methylnaltrexone

Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection.

Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer

Correction: Prevention of Vγ9Vδ2 T Cell Activation by a Vγ9Vδ2 TCR Nanobody

Cutting edge: Rapid recovery of NKT cells upon institution of highly active antiretroviral therapy for HIV-1 infection

Differential effects of inhibitors of the PI3K/mTOR pathway on the expansion and functionality of regulatory T cells.

Effects of alpha-galactosylceramide (KRN7000), interleukin-12 and interleukin-7 on phenotype and cytokine profile of human Valpha24+ Vbeta11+ T cells

Ex vivo analysis of resident hepatic pro-inflammatory CD1d-reactive T cells and hepatocyte surface CD1d expression in hepatitis C.

Exploiting regulatory T-cell populations for the immunotherapy of cancer.

Exploiting the CD1d-iNKT cell axis for potentiation of DC-based cancer vaccines

Expression of granzyme B during primary cytomegalovirus infection after renal transplantation

Generation and characterization of CD1d-specific single-domain antibodies with distinct functional features

Generation of antitumor invariant natural killer T cell lines in multiple myeloma and promotion of their functions via lenalidomide: a strategy for immunotherapy.

Gram-positive bacteria: a major microbial ‘turn-on’ for invariant NKT cells

Hepatitis C Virus (HCV)-Specific CD8+ Cells Produce Transforming Growth Factor That Can Suppress HCV-Specific T-Cell Responses

High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status

Highly specific and potently activating Vγ9Vδ2-T cell specific nanobodies for diagnostic and therapeutic applications.

Human natural killer T cells acquire a memory-activated phenotype before birth

IPEX as a result of mutations in FOXP3

Immunological effects of everolimus in patients with metastatic renal cell cancer

In Vivo Efficacy of Umbilical Cord Blood Stem Cell-Derived NK Cells in the Treatment of Metastatic Colorectal Cancer

Invariant natural killer T cells and immunotherapy of cancer.

Irinotecan-induced dysarthria.

Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma

MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursors.

Mechanisms of intimate and long-distance cross-talk between glioma and myeloid cells: how to break a vicious cycle.

Megacolon during treatment with lactulose

Multiple pseudotumors in IgG4-associated multifocal systemic fibrosis

Myocardial air collections as a result of infection with a gas producing strain of Escherichia coli.

Natural Killer T cells

Natural killer T cell-based cancer immunotherapy

Nuancing the proposed role of NKT cells in aging ⬇️

Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis

Peripheral blood IFN-gamma-secreting Valpha24+Vbeta11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load

Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-Based Chemoradiation in Locally Advanced Pancreatic Cancer.

Polarization of Valpha24+ Vbeta11+ natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cells

Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15

Preoperative chemoradiation therapy in combination with panitumumab for patients with resectable esophageal cancer: the PACT study

Prevention of Vγ9Vδ2 T Cell Activation by a Vγ9Vδ2 TCR Nanobody.

Quantification of Bax/Bcl-2 ratios in peripheral blood lymphocytes, monocytes and granulocytes and their relation to susceptibility to anti-Fas (anti-CD95)-induced apoptosis

Randomized phase 2 study of gemcitabine and cisplatin with or without vitamin supplementation in patients with advanced esophagogastric cancer.

Response to Comment on "mTOR Inhibition Per Se Induces Nuclear Localization of FOXP3 and Conversion of Invariant NKT (iNKT) Cells into Immunosuppressive Regulatory iNKT Cells".

Schistosomiasis

Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection

Severe toxicity of capecitabine following uncomplicated treatment with 5-fluorouracil/leucovorin

Standardized and flexible eight colour flow cytometry panels harmonized between different laboratories to study human NK cell phenotype and function.

Statistical controversies in clinical research: overlap and errors in the meta-analyses of microRNA genetic association studies in cancers.

Synergistic effect of KRN7000 with interleukin-15, -7, and -2 on the expansion of human V alpha 24+V beta 11+ T cells in vitro

The CD8+ granzyme B+ T-cell subset in peripheral blood from healthy individuals contains activated and apoptosis-prone cells.

The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments.

The effects of systemic treatment with aminobisphosphonates and statins on circulating Vγ9Vδ2-T cells in patients with advanced cancer

The immunoregulatory role of CD1d-restricted natural killer T cells in disease.

Vγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy.

mTOR Inhibition Per Se Induces Nuclear Localization of FOXP3 and Conversion of Invariant NKT (iNKT) Cells into Immunosuppressive Regulatory iNKT Cells